GS MedTech Funding Tracker – CereVasc, Subtle Medical, and more

GS Funding Tracker
A strong week for clinical-stage MedTech, with investors doubling down on technologies built for clinical impact - this week’s tracker highlights major raises across AI imaging, cardiovascular devices, and robotic surgery. Details follow below. CereVasc...

GS MedTech Funding Tracker – CereVasc, Subtle Medical, and more

GS Funding Tracker
A strong week for clinical-stage MedTech, with investors doubling down on technologies built for clinical impact - this week’s tracker highlights major raises across...

CereVasc closes $85M Series C to support eShunt system

Funding
CereVasc announced that it completed the initial closing of an $85 million Series C financing round to support its eShunt system. Piper Sandler Merchant Banking...

Petal Surgical adds more funding for incisionless surgical robot

Funding
Petal Surgical announced a new financing round to support its incisionless surgery platform as it works toward first-in-human studies. Blue Pool Capital led the latest...

Advanced NanoTherapies raises $31M for drug-coated balloon tech

Funding
Advanced NanoTherapies announced that it closed an oversubscribed Series B financing worth more than $31 million. An undisclosed strategic investor, along with S3 Ventures, co-led...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Picard Medical’s SynCardia completes milestone study of next-gen total artificial heart

Picard Medical, parent company of SynCardia, announced the completion of an in vivo study of its Emperor platform. The company completed an acute in vivo...

Reflow Medical has positive data for coronary drug-eluting stent

Reflow Medical announced the first six-month clinical results from a study of its Spur Elute sirolimus-eluting retrievable stent system. San Clemente, California-based Reflow designed its...

EmStop initiates IDE study of novel embolic protection device

EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS). CAPTURE-2 evaluates the safety and...

Reprieve Cardiovascular pilot study backs heart failure system

Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy. Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...

Innovation

Regulatory Approvals

GS MedTech Funding Tracker – CereVasc, Subtle Medical, and more

A strong week for clinical-stage MedTech, with investors doubling down on technologies built for clinical impact - this week’s tracker highlights major raises across...

CereVasc closes $85M Series C to support eShunt system

CereVasc announced that it completed the initial closing of an $85 million Series C financing round to support its eShunt system. Piper Sandler Merchant Banking...

Petal Surgical adds more funding for incisionless surgical robot

Petal Surgical announced a new financing round to support its incisionless surgery platform as it works toward first-in-human studies. Blue Pool Capital led the latest...

Advanced NanoTherapies raises $31M for drug-coated balloon tech

Advanced NanoTherapies announced that it closed an oversubscribed Series B financing worth more than $31 million. An undisclosed strategic investor, along with S3 Ventures, co-led...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1149Regulatory Approvals1021Innovation655Clinical Trials523Mergers & Acquisitions509GS Funding Tracker52